Vanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects. This represents a new target for drug development that could fill a major gap in care for depression. The research was led by Lisa Monteggia, professor of pharmacology and director of the Vanderbilt Brain Institute, Ege Kavalali, professor…
New symptoms identified that could help doctors diagnose pancreatic cancer
Researchers have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognised symptoms—feeling thirsty and having dark urine—in a study presented today at the NCRI Festival. The study has confirmed a further 21 signs of pancreatic cancer and shown that patients often have some symptoms of the…
New therapeutic molecule yields new hope for Duchenne muscular dystrophy patients
A research team led by Nicolas Dumont, a researcher at CHU Sainte-Justine and professor at the Université de Montréal, has discovered a new therapeutic molecule, Resolvin-D2. It has the potential to significantly improve the quality of life of patients with Duchenne muscular dystrophy (DMD) by stimulating muscle stem-cell activity. DMD…
Russia hits new record for COVID-19 deaths, resists lockdown
Russia hit another record of daily coronavirus deaths Tuesday as the country struggled with a rapid surge of infections and lagging vaccination rates, but authorities have been adamant that there would be no new national lockdown. The government coronavirus task force reported 973 coronavirus deaths, the highest daily toll since…
Researchers develop a new way to find cancer at the nanometer scale
Diagnosing and treating cancer can be a race against time. By the time the disease is diagnosed in a patient, all too often it is advanced and able to spread throughout the body, decreasing chances of survival. Early diagnosis is key to stopping it. In a new Concordia-led paper published…
EPA plans new strategy against PFAS ‘forever chemicals’
(HealthDay) —- A new plan to limit pollution from so-called “forever chemicals” will include restricting their release into the environment and speeding cleanup of contaminated sites, the U.S. Environmental Protection Agency announced Monday. The chemicals, called PFAS (per- and polyfluoroalkyl substances), are used in products ranging from cookware to carpets…
FDA takes new action to improve quality and efficacy of sunscreens
As part of its ongoing implementation of new authorities for certain over-the-counter (OTC) drugs, the U.S. Food and Drug Administration has taken actions aimed at improving the quality, safety, and efficacy of sunscreens. The provisions in the Sept. 24 proposed order closely follow a 2019 proposed rule on sunscreens and…
New analysis shows use and predictors of low-value care in health systems nationwide
Researchers estimate that up to $101 billion in health care spending is wasted each year due to over-treatment or the delivery of “low-value care.” Low-value care includes a wide array of tests and treatments that are medically unnecessary and for which the potential for harm outweigh the potential for benefit….
New potential targets to approach the treatment for neuropsychiatric disorders
A study published in the journal Pharmacological Research describes the existence of a complex built by dopamine and noradrenergic receptors that could be a therapeutic target of potential interest to tackle the attention deficit hyperactivity disorder (ADHD) and impulsivity. The paper, a preclinical study, has been carried out by the…
Georgia Eyes New Medicaid Contract. But How Is the State Managing Managed Care?
Just before Frank Berry left his job as head of Georgia’s Medicaid agency this summer, he said the state “will be looking for the best bang for the buck” in its upcoming contract with private insurers to cover the state’s most vulnerable. But whether the state — and Medicaid patients…
New discovery on the progression of dementia in Parkinson’s
An international study featuring Murdoch researchers has discovered a genetic variant with a five times higher risk factor for predicting the progression of dementia. Dementia is one of the most debilitating symptoms of disease progression in people with Parkinson’s disease, with a huge influence on quality of life, care givers…